Dr Ann Livingstone

Adjuvant immunotherapy recommendations for stage III melanoma: physician and nurse interviews

A Livingstone, K Dempsey, M Stockler, K Howard, G Long, M Carlino, A Menzies, R Morton

(2021), Vol. 21, BMC Cancer, C1-1

Should I Have Adjuvant Immunotherapy? An Interview Study Among Adults with Resected Stage 3 Melanoma and Their Partners

A Livingstone, D Milne, K Dempsey, D Muscat, A Menzies, K Howard, M Stockler, R Morton

(2021), Vol. 14, pp. 635-647, Patient, C1-1

Is routine distal clavicle resection necessary in rotator cuff repair surgery? A systematic review and meta-analysis

A Livingstone, R Asaid, A Moaveni

(2019), Vol. 11, pp. 39-45, Shoulder and Elbow, C1-1

Continuing or ceasing bevacizumab beyond progression in recurrent glioblastoma: An exploratory randomized phase II trial

E Hovey, K Field, M Rosenthal, E Barnes, L Cher, A Nowak, H Wheeler, K Sawkins, A Livingstone, P Phal, C Goh, J Simes, P Kelly, A Hayden, E Barnes, D Espinoza, C Brown, D Winter, B Tomes, R Pike, J Simes, L Garrett, H Kilsby, R Freilich, I Arzhintar, A Dowling, N Ranieri, R Jennens, F Osmond, K Patterson, A Phay, A Byrne, S Begbie, P Williams, S Kirby-Lewis, F Abell, L Plowman, J Flynn, P Inglis, A Ives, S Lobb, Z Lwin, N Woodward, G Crosbie, N Singhal, S Smith, M Whelan

(2017), Vol. 4, pp. 171-181, Neuro-Oncology Practice, C1-1

Validating self-report and proxy reports of the Dexamethasone Symptom Questionnaire -Chronic for the evaluation of longer-term corticosteroid toxicity

M Agar, E Koh, E Gibbs, E Barnes, E Hovey, A Livingstone, K Sawkins, R Chye, M Lovell, K Clark, J Vardy, M King

(2016), Vol. 24, pp. 1209-1218, Supportive Care in Cancer, C1-1